M
Monica Gandhi
Researcher at University of California, San Francisco
Publications - 310
Citations - 9315
Monica Gandhi is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 43, co-authored 264 publications receiving 6478 citations. Previous affiliations of Monica Gandhi include Partners HealthCare & University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.
TL;DR: Traditional infection-control and public health strategies rely heavily on early detection of disease to contain spread, but when Covid-19 burst onto the global scene, public health officials initially doubted its ability to tackle infectious disease outbreaks.
Journal ArticleDOI
Sex Differences in Pharmacokinetics and Pharmacodynamics
TL;DR: This review examines the biologic basis of differences in pharmacokinetics and pharmacodynamics between the sexes and summarizes studies that have addressed these differences.
Journal ArticleDOI
Association of Cigarette Smoking With HIV Prognosis Among Women in the HAART Era: A Report From the Women’s Interagency HIV Study
Joseph G. Feldman,Howard Minkoff,Michael F. Schneider,Stephen J. Gange,Mardge H. Cohen,D. Heather Watts,Monica Gandhi,R. Mocharnuk,Kathryn Anastos +8 more
TL;DR: Some of the benefits provided by HAART are negated in cigarette smokers, and the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy among low-income women is assessed.
Journal ArticleDOI
Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.
TL;DR: Facial Masking for Covid-19 Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deactivated.
Journal ArticleDOI
Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer.
TL;DR: The hypothesis that universal masking reduces the “inoculum” or dose of the virus for the mask-wearer, leading to more mild and asymptomatic infection manifestations is discussed for one of the first times.